Avalon GloboCare Corp.
NASDAQ Capital MarketRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Avalon GloboCare Corp. (NASDAQ: ALBT) develops and delivers precision diagnostics, clinical laboratory services, and related healthcare technologies. The company offers clinical laboratory testing including bloodwork, anatomic pathology, urine and drug toxicology, STAT blood and genetic testing, pharmacogenomic (PGx) testing via real-time PCR, and wellness diagnostics through its Lab Services MSO segment, in which it holds a 40% membership interest acquired in February 2023; distributes the FDA-registered KetoAir breathalyzer device featuring nanosensor technology for real-time breath acetone (BrAce) measurement to monitor ketosis and fat metabolism, supported by compatible iOS and Android apps and the AI Nutritionist software for ketogenic diet management; advances the QTY protein design platform, joint intellectual property with Massachusetts Institute of Technology (MIT), for water-soluble cytokine receptor variants; and develops cell-based immunotherapies including bispecific Anti-CD19xCD22 CAR-T and CAR-NK technologies with localized cytokine induction, protected by patents in the United States, China, Hong Kong, and PCT jurisdictions. Avalon GloboCare operates primarily in the United States with recent expansions including a United Kingdom launch of KetoAir on September 1, 2025, and programs targeting first responders through partnerships with Saga Health Corporation, SpecialtyHealth, and Pounds Transformation Clinics. Founded in 2016 and headquartered in Freehold, New Jersey, the company has pursued strategic growth through a proposed merger with YOOV Group Holding Limited, announced in March 2025 and advancing with an SEC Form S-4 filing, to integrate AI-as-a-Service solutions for business automation; a co-development agreement with Qi Diagnostics for a VOC nanosensor-based cannabis breathalyzer; wholesale distribution deals for KetoAir; and new intellectual property protections enhancing its immunotherapy portfolio.
Avalon Quantum AI teams up with Caylent and Amazon Web Services on Agentic AI Platform Development
Powell Max Limited Successfully Repositions for Its Next Phase of Growth
Avalon GloboCare Corp. (NASDAQ:ALBT) Short Interest Update
Stock Market Today: S&P 500, Dow Jones Futures Slide Amid War Against Iran— AMTD Digital, Aardvark, MongoDB In Focus
Avalon GloboCare Announces Closing of up to $9.75 Million Private Placement Priced At-the-Market under Nasdaq Rules
Avalon GloboCare Announces up to $9.75 Million Private Placement Priced At-the-Market under Nasdaq Rules
Avalon GloboCare (ALBT) Stock Surges On AMD AI News
Top 3 Real Estate Stocks Which Could Rescue Your Portfolio This Month
FDA Green Lights Avalon GloboCare's KetoAir Breathalyzer
Head to Head Survey: Avalon GloboCare (NASDAQ:ALBT) versus Fortrea (NASDAQ:FTRE)
Avalon GloboCare Regains Compliance with Nasdaq Stockholders' Equity Requirement, Launches Marketing for Automated Generative AI Video Platform
Head-To-Head Analysis: Greenwich LifeSciences (NASDAQ:GLSI) vs. Avalon GloboCare (NASDAQ:ALBT)
S&P 500, Nasdaq wrap up 2025 with impressive annual rises despite year-end dip
Nasdaq, Dow Jones edge lower as Fed minutes show division over December rate cut
Avalon GloboCare Board Director Highlights RPM Interactive's Automated Generative AI Video Creation Platform in Interview with ProactiveInvestors.com
Storage and memory stocks lead S&P 500 gains in 2025
Invinity shares rise as group lands first Endurium Enterprise order
Avalon GloboCare Corp. (NASDAQ:ALBT) Short Interest Up 41.2% in December
S&P 500 hits another record as stocks rally into Christmas
Nike shares rise as Tim Cook purchases $2.95M in stock